Device-Enabled Disease Management for Heart Failure

Service-based heart failure management initiatives are evidently unable to deliver economic benefits, as evidenced by the "South Texas CHF Disease Management Project", results of which were presented at the American Heart Association meeting in November, but device companies think they can. Several , including Medtronic and CHF Solutions are setting out to demonstrate the benefits of device-enabled fluid management in congestive heart failure patients. Fluid overload accounts for 90% of hospitalizations for heart failure, and heart failure is the number one reason for hospital admissions in the US.